HCG Peptide

Price range: €49.99 through €189.96

Technical Specifications

Specification	Detail
Product Name	HCG Peptide (Human Chorionic Gonadotropin)
Quantity	5000 IU per vial
Purity	≥98% (HPLC verified)
Form	Lyophilized powder
Appearance	White to off-white lyophilized powder
Molecular Weight	~36,700 Da
CAS Number	9002-61-3
Alpha Subunit	92 amino acids
Beta Subunit	145 amino acids
Target Receptor	Luteinizing hormone/choriogonadotropin receptor (LHCGR)
Half-Life	24-36 hours
Key Research Areas	Male reproductive endocrinology, female reproductive endocrinology, fertility research, androgen research, hypogonadism, cryptorchidism, delayed puberty
Storage (Lyophilized)	2-8°C; protect from light and moisture
Storage (Reconstituted)	2-8°C; use within 30-60 days; do not freeze
Shelf Life	24 months from manufacture date (lyophilized)
Shipping	Ambient temperature with protective packaging
Intended Use	Research and laboratory use only
Documentation	Certificate of Analysis provided with each batch

SKU: N/A Categories: Buy Peptide Online UK, Peptides Tags: #outreach, ≥98% purity, 17-beta-hydroxysteroid dehydrogenase, 17-hydroxyprogesterone, 3-beta-hydroxysteroid dehydrogenase, 3Rs, 48 hour delivery peptide, 5-alpha reductase deficiency, 510(k), 700 Da, ABP, abstracts, AC, academic medical centers, academic research organizations, academic-industry partnership, accelerated approval, accelerated stability, acceptance sampling, access policy, access to care, accessible, accountable care, acquisition, acquisition agreement, activin, adaptive design, adenylyl cyclase, adherence, adherence programs, ADME, adolescent medicine, adrenal androgens, ADT, adverse effects, adverse event prediction, adverse outcome pathways, advisory boards, advisory groups, AFC, affinity, affordability, AI, AIaMD, AIS, aldosterone, algorithm validation, alliances, alternative methods, ambiguous genitalia, amenorrhea, AMH, analytical method development, androgen deprivation therapy, androgen excess, androgen insensitivity syndrome, Androgen receptor, androgen receptor research, androgen research, androgen-binding protein, andropause, androstenedione, angel investment, animal testing, animal welfare, anovulation, anti-androgens, anti-counterfeiting, anti-Müllerian hormone, antral follicle count, AOP, application support, applied research, ARO, artificial intelligence, artificial intelligence as a medical device, aseptic processing, assisted reproduction, association rate, audit, authenticity, authorship, basic science, basket trials, batch release, batch release testing, Bayesian design, benefit risk assessment, best practice, bioassay, bioavailability, bioavailable testosterone, biobanks, bioburden, biodegradable materials, bioequivalence, Bioidentical hormones, bioinformatics, Biomarker discovery, biosimilar competition, biosimilars, bisphenol A, blockchain, Bmax, BPA, brand loyalty, breakthrough device, breast cancer research, Budget impact, business continuity, business development, buy HCG EU, buy HCG UK, buy peptide online EU, buy peptide online UK, CAH, cAMP, cAMP assay, cAMP signaling, CAPA, carbon footprint, carboxy-terminal peptide, Carcinogenicity, care coordination, care pathway, career development, caregiver burden, CAS 9002-61-3, case-control studies, castration-resistant prostate cancer, category management, CDA, CDS, CE mark, cell-based assay, cellular signaling, change control, change management, child resistant packaging, cholesterol side-chain cleavage, cholesterol transport, Chromatin remodeling, claims data, cleanroom qualification, clearance, climate change, clinical affairs, clinical decision support, clinical endpoints, clinical evidence, clinical guideline, clinical outcomes, clinical pharmacy, clinical research networks, clinical translation, clinical trial application, clinical validation, clinical workflow, clinician-reported outcomes, ClinRO, close-out, closing, co-pay assistance, coalitions, COH, cohort studies, COI, cold chain, cold chain management, collaboration, collaboration agreement, collaborations, combination therapy, comment period, commercial manufacturing, commercialization, committees, community hospitals, community outreach, companion diagnostics, comparative effectiveness, compassionate use, competitive advantage, competitive binding, competitive landscape, compliance, compliance audit, compliance packaging, composite endpoints, composition of matter, computational biology, computational modeling, computer vision, concentration response, conditional approval, conference presentations, Confidentiality, confidentiality agreement, conflict minerals, conflict of interest, congenital adrenal hyperplasia, connected devices, consortia, content marketing, contingency planning, continuing education, continuous improvement, continuous monitoring, contract research organizations, contractual agreements, controlled ovarian hyperstimulation, core facilities, corporate social responsibility, corpus luteum, corpus luteum support, corrective action, Cortisol, cost reduction, cost-effectiveness, CREB, CRO, cross-reactivity, cross-sectional studies, crossover, CRPC, cryptorchidism, cryptorchidism research, CSR, CTA, CTP, cultural integration, culture, custom compounding, customer acquisition, customer retention, customer service, Cybersecurity, Data breach, data citation, data curation, data integrity, data loggers, data management, data preservation, Data protection, Data sharing, data stewardship, DAX1, de novo, decentralized clinical trials, deep learning, dehydroepiandrosterone, DEI, delayed puberty, delayed puberty research, desensitization, design of experiments, developmental origins of health and disease, developmental toxicity, deviation management, DHEA, DHEA-S, DHEA-sulfate, DHT, differentiation, digital endpoints, digital health, digital marketing, digital therapeutics, dihydrotestosterone, disaster recovery, disclosure, disease advocacy, disease progression, disorders of sex development, dissemination research, dissociation rate, distribution, diversity, diversity in STEM, DNA methylation, documentation, DoE, DOHaD, DOI, Dose escalation, Dose response, Double blind, downregulation, Drug discovery, drug repositioning, Drug repurposing, drug-drug interactions, DSD, DTx, due diligence, early-career researchers, EBM, eco friendly packaging, Economic burden, EDCs, education, efficacy, efficacy biomarkers, efficiency improvement, egg retrieval, EHR, electronic health records, EMA inspection, email marketing, embryo implantation, Embryo transfer, embryotoxicity, employee engagement, Endocrine disruptors, endocrine research, endocrine-disrupting chemicals, endocytosis, endometrial cancer research, endometrial receptivity, Endotoxin testing, enrollment, environmental, environmental enrichment, environmental estrogens, environmental health, environmental monitoring, epigenetic regulation, equilibrium binding, equity, ESG, estradiol, estriol, estrogen research, estrone, ethical approval, ethical review, ethical sourcing, ethics, ethics committee, EU Horizon, EU peptide supplier, eupeptidelap peptide, evidence-based medicine, exceptional circumstances, exclusivity, excretion, exocytosis, expanded access, expedited pathway, exploratory endpoint, factorial design, FAIR principles, fair trade, FDA approval, FDA clearance, FDA inspection, feasibility study, female infertility, female reproductive research, fertility preservation, Fertility research, fetal development, Fetal programming, filtration, findable, follicle-stimulating hormone, Folliculogenesis, follistatin, follow-on biologics, forced degradation, formulary management, formulation patent, foundation support, free testosterone, freeze drying, FSH, FTIR, functional assay, functional outcomes, fundamental biology, G protein-coupled receptor, GC MS, GDPR, gene expression profiling, gene transcription, generic competition, generic drug development, genetic testing, Genotoxicity, geriatric endocrinology, germ cell development, germ cell tumors, Global health, global health security, glycoprotein hormone, glycoprotein stability, glycosylated hormone, glycosylation, GMP facility, GMP manufacturing, GnRH, gonadal dysgenesis, gonadarche, Gonadotropin research, gonadotropin stimulation, gonadotropin therapy, gonadotropin-releasing hormone, governance, GPCR, graduate students, grant funding, granulosa cell, granulosa cell research, green chemistry, growth equity, guidance, half-life, hard endpoints, hCG, hCG alpha subunit, hCG beta subunit, HCG EU, HCG for sale EU, HCG for sale UK, HCG peptide, health disparities, health economics, health equity, health insurance, Health policy, health related quality of life, health technology assessment, heterologous desensitization, high purity peptide, Histone modification, homologous desensitization, Hormone replacement therapy, hospital pharmacy, housing standards, HPG axis, HPLC, HRQoL, HRT, HTA, human chorionic gonadotropin, human rights, humane endpoints, hypergonadotropic hypogonadism, hypogonadism, hypogonadism research, hypogonadotropic hypogonadism, hypospadias, hypothalamic-pituitary-gonadal axis, IACUC, IATA, idea evaluation, idea generation, immunogenicity, impact, implantation window, implementation science, impurity profiling, In silico modeling, in vitro fertilization, in vitro toxicology, inclusion, IND, IND enabling studies, indemnification, industry associations, influencer marketing, Informed consent, inhibin, initial public offering, innovation, innovation management, inspection, institutional oversight, insurance, integrated approaches to testing and assessment, integrated care, integration, integrity, intellectual property, international collaboration, interoperable, intersex conditions, inventory management, investigational new drug, investment agreement, IoT sensors, IPO, IRB, ISO 14644, ISO certification, IVF research, joint venture, joint venture agreement, Kallmann syndrome, Kd, key opinion leaders, kinetics, Klinefelter syndrome, knowledge management, KOLs, labeling, labor standards, laboratory reagent, LAL, LC-MS, leadership, leadership development, lean manufacturing, legacy, legal affairs, legislation, Leydig cell, Leydig cell biology, Leydig cell stimulation, LH, LH replacement, LHCGR agonist, liability, license agreement, licensing, lifecycle management, ligand receptor interaction, line extension, LMIC, logistics, long-term stability, longitudinal studies, low- and middle-income countries, luciferase reporter, luteal phase, luteal phase deficiency, luteal phase support, luteinizing hormone, luteinizing hormone receptor, luteinizing hormone receptor agonist, lyophilization, lyophilized powder, lysosomal degradation, MAA filing, machine learning, male infertility, male reproductive research, manufacturing scale-up, market access, market analysis, market launch, market leadership, market penetration, market share, marketing authorization, master protocols, material transfer agreement, MDT, media relations, medical affairs, medical societies, medication adherence, medication management, men's health, menarche, menopause, mentorship, merger, merger agreement, metabolism, Metabolomics, metadata, method of use, method validation, mHealth, MHRA inspection, micro-TESE, microbial limits, micropenis, microphysiological systems, mission, mitochondrial steroidogenesis, mobile health, molecular diagnostics, molecular endocrinology, molecular weight 36, monitoring, MTA, Müllerian duct, multidisciplinary team, multigenerational studies, multivariate analysis, Mutagenicity, named patient program, NAMs, national health service, natural language processing, NDA, NDA filing, negative feedback, neglected diseases, negotiation, net zero, networks, neutralizing antibodies, new approach methodologies, new drug application, new indication, next day delivery peptide, NHS, NIH, NLP, NMR, non-responder identification, observer-reported outcomes, ObsRO, off label use, off target effects, oligomenorrhea, oncofertility, one health, oocyte cryopreservation, oocyte development, Oocyte maturation, open access, Open label, Open science, operational excellence, option agreement, ORCID, organ-on-a-chip, organizational culture, orphan drug designation, orphan drug exclusivity, out-of-pocket, outcome prediction, outcomes research, ovarian cancer research, ovarian physiology, ovarian reserve, ovarian steroidogenesis, ovarian stimulation, ovary determination, ovulation induction, ovulation trigger, P450 aromatase, P450 side-chain cleavage, P450c17, P450scc, packaging, pandemic preparedness, parallel group, partnership, partnerships, PAT, patent, patent litigation, patent term extension, patient advocacy, patient assistance, patient centered care, patient engagement, patient organizations, patient outcomes, patient perspective, patient recruitment, patient satisfaction, patient stratification, patient support, patient-centricity, patient-reported outcomes, PCOS, PCOS research, pediatric endocrinology, pediatric exclusivity, peer-reviewed journals, peptide for sale EU, peptide for sale UK, PerfO, performance management, performance outcomes, perimenopause, perinatal development, persistence, persistent identifiers, personalized dosing, personalized medicine, pharmaceutical care, Pharmacodynamics, pharmacoeconomics, pharmacogenetics, Pharmacogenomics, pharmacokinetics, pharmacovigilance, pharmacy compounding, Phase 1 trial, Phase 2 trial, Phase 3 trial, philanthropic funding, phthalates, pilot study, PKA, PKA activation, planetary health, platform trials, PMA, POI, policy, polycystic ovary syndrome, population health, Positive feedback, post translational modification, post-launch monitoring, post-marketing surveillance, post-merger integration, postdoctoral fellows, posters, postnatal development, potency, precision medicine, preclinical development, preclinical safety, predictive modeling, pregnenolone, premarket approval, premature ovarian insufficiency, prenatal exposure, preprint, prescription digital therapeutics, preventive action, Pricing strategy, primary endpoint, primary hypogonadism, primary ovarian insufficiency, priority review, privacy, private insurance, private practice, PRO, process analytical technology, process patent, process validation, procurement, procurement optimization, product launch, product optimization, professional development, professional societies, profit margin, progesterone, progesterone production, progesterone research, proof of concept, prospective studies, prostate cancer research, proteasome, protein folding, protein kinase A, protein secretion, protein stability, Protein synthesis, Proteomics, protocol, prototyping, PTE, Pubertal development, puberty onset, public consultation, Public engagement, Public health, public health impact, public-private partnership, publication ethics, publications, purpose, pyrogen testing, QbD, QSAR, quality assurance, quality audit, quality by design, quality control, quality of life, quality systems, Radioligand binding, randomized controlled trials, rare disease, rare diseases, RCR, RCT, RDM, read-across, Real world data, real-world evidence, receptor binding, Receptor binding assay, receptor internalization, receptor pharmacology, receptor recycling, recurrent implantation failure, recurrent pregnancy loss, recyclable materials, reduced packaging, reduction, reference laboratories, refinement, reformulation, registries, regulation, Regulatory affairs, regulatory clearance, regulatory inspection, regulatory policy, Regulatory science, regulatory toxicology, reimbursement, reimbursement policy, remote monitoring, renewable energy, replacement, replicability, repositioning, reproducibility, reproductive biology, Reproductive endocrinology, reproductive medicine, Reproductive toxicity, reproductive toxicology, reproductive tract development, repurposing, Research compound, research council, research data management, research ethics, research governance, Research grade, Research infrastructure, Research integrity, research peptide, research peptide EU, research peptide UK, responder identification, responsible conduct of research, retention, retention strategies, retrospective studies, reusable, revenue generation, RFID, risk assessment, risk management, risk prediction, risk-benefit assessment, RNA sequencing, roadmap, rulemaking, RWD, RWE, SAB, safety biomarkers, safety margin, Safety pharmacology, sales growth, SaMD, SBIR, scale up, Scatchard analysis, Science communication, scientific advisory board, scientific communication, Scientific rigor, scientific workforce, SDOH, Second messenger, secondary endpoint, secondary hypogonadism, security, security features, seed funding, selectivity, SEM, senior friendly packaging, SEO, serialization, series A, series B, Sertoli cells, sex determination, sex hormone binding globulin, sex reversal, sexual differentiation, SF1, Shared decision making, shareholder agreement, SHBG, sialic acid, sialic acid content, sialylation, signal transduction, single blind, single-cell RNA-seq, site initiation, site management organizations, Six Sigma, smart packaging, SMO, social, social determinants of health, social media, societal impact, software as a medical device, SOP, sourcing, SOX9, spatial transcriptomics, SPC, specials, specificity, Spermatogenesis, spermatogenesis research, spermatogenic cycle, sponsored research agreement, SRA, SRY gene, stability testing, stakeholder engagement, Standard operating procedure, StAR protein, statistical process control, STEM education, sterility testing, steroid hormone biosynthesis, steroidogenesis, steroidogenesis research, steroidogenic acute regulatory protein, steroidogenic enzyme defects, strategic planning, strategic sourcing, strategy, Stratified medicine, STTR, study start-up, succession planning, supplier management, supply chain ethics, supply chain management, supply chain visibility, surrogate endpoints, sustainability, Sustainable development, sustainable sourcing, SWOT analysis, symposia, synergy realization, systems biology, talent acquisition, talent development, tamper evident packaging, task forces, teaching hospitals, Technical support, technology transfer, telemedicine, temperature controlled shipping, temperature monitoring, Teratogenicity, term sheet, terminal sterilization, TESE, testicular atrophy, testicular biopsy, testicular cancer research, testicular descent, testicular feminization, testicular function, testicular physiology, testicular sperm extraction, testis determination, testosterone, testosterone biosynthesis, testosterone deficiency, testosterone production, testosterone replacement, theca cell, theca cell research, Theranostics, therapeutic index, thought leadership, tissue repositories, tolerability, total testosterone, toxicity, Toxicology, traceability, track and trace, trade groups, training, transcription factor, Transgenerational inheritance, translation to practice, Translational research, transparency, treatment algorithm, treatment optimization, treatment response, tropical diseases, TRT, Turner syndrome, two-generation studies, ubiquitination, UK peptide vendor, UKCA mark, umbrella trials, undergraduate research, underrepresented minorities, underserved populations, undescended testes, unlicensed medicines, UPLC, UV-Vis, valuation, value engineering, value proposition, value-based care, values, varicocele, vendor qualification, venture capital, vesicular transport, Veterinary Care, vial filling, virtual trials, vision, volume of distribution, waste reduction, wearable devices, webinars, weight of evidence, Wolffian duct, women in science, women's health, workforce development, working groups, workshops, WT1, xenoestrogens, xo, XXY

Premium HCG (Human Chorionic Gonadotropin) for Sale | 5000 IU Lyophilized Powder | ≥98% Purity | 48-Hour Delivery Across EU & UK

HCG Peptide: The Essential Gonadotropin for Advanced Endocrine Research

Buy HCG Peptide EU & UK, Eupharmaceutical is proud to present HCG Peptide (Human Chorionic Gonadotropin), a premium research-grade glycoprotein hormone manufactured to the highest analytical standards. As a trusted peptide vendor uk and leading EU peptide supplier, we provide researchers across Europe with HCG for sale that delivers exceptional purity, consistency, and documented quality for advanced studies in reproductive endocrinology, testicular function, and luteinizing hormone receptor signaling. Buy HCG Peptide EU & UK

Human Chorionic Gonadotropin (HCG) is a glycoprotein hormone composed of two non-covalently linked subunits: an alpha subunit (92 amino acids) identical to that of luteinizing hormone (LH), follicle-stimulating hormone (FSH), and thyroid-stimulating hormone (TSH), and a unique beta subunit (145 amino acids) that confers biological specificity . First discovered in 1927 by Ascheim and Zondek in the urine of pregnant women, HCG is naturally produced by the syncytiotrophoblast cells of the placenta during pregnancy, where it maintains corpus luteum function and progesterone production .

HCG functions primarily as a potent agonist of the luteinizing hormone/choriogonadotropin receptor (LHCGR), a G protein-coupled receptor expressed predominantly in the testes (Leydig cells) and ovaries (theca and granulosa cells) . Upon binding, HCG activates the cAMP/PKA signaling cascade, stimulating steroidogenesis and promoting the production of testosterone in males and progesterone in females . Unlike LH, which is secreted in a pulsatile manner with a short half-life (approximately 20-30 minutes), HCG has a significantly longer half-life (approximately 24-36 hours), making it a valuable tool for sustained receptor activation studies . Buy HCG Peptide EU & UK

For researchers seeking to buy peptide online EU for investigations into male hypogonadism, testicular function, fertility research, or steroidogenesis pathways, Eupharmaceutical offers this premium research compound with comprehensive documentation, including Certificates of Analysis and batch-specific purity data. Whether your laboratory is based in London, Berlin, Paris, or anywhere in the European Union, our guaranteed 48 hour delivery peptide service ensures your research continues without interruption.

The Scientific Foundation of HCG Peptide Research

Discovery and Historical Significance

HCG was first identified in 1927 by German gynecologists Selmar Ascheim and Bernhard Zondek, who discovered its presence in the urine of pregnant women and developed the first pregnancy test based on this finding . For decades, HCG was used clinically as a diagnostic marker for pregnancy, and later as a therapeutic agent for treating infertility and hypogonadism. Its ability to mimic LH activity and stimulate testosterone production in males has made it a cornerstone of reproductive endocrinology research.

Molecular Structure and Composition

HCG is a heterodimeric glycoprotein with a molecular weight of approximately 36,700 Da . Its structure comprises:

Alpha Subunit (α-hCG): A 92-amino acid polypeptide (14,500 Da) identical to the alpha subunits of LH, FSH, and TSH
Beta Subunit (β-hCG): A 145-amino acid polypeptide (22,500 Da) unique to HCG, conferring biological specificity and longer half-life
Carbohydrate Content: Approximately 30% of the molecular weight is carbohydrate, including sialic acid residues that extend plasma half-life

The unique carboxy-terminal peptide (CTP) of the beta subunit contains four O-linked oligosaccharides that protect HCG from rapid hepatic clearance, contributing to its extended half-life compared to LH .

Mechanism of Action: Luteinizing Hormone Receptor Activation

HCG exerts its effects through specific binding to the luteinizing hormone/choriogonadotropin receptor (LHCGR), a G protein-coupled receptor (GPCR) expressed on Leydig cells in the testes and theca/granulosa cells in the ovaries .

Receptor Binding: HCG binds to LHCGR with high affinity (Kd ≈ 0.2-0.5 nM), triggering conformational changes that activate the receptor’s intracellular signaling domains .

Signal Transduction: Activated LHCGR couples to Gs proteins, stimulating adenylyl cyclase and increasing intracellular cAMP levels . Elevated cAMP activates protein kinase A (PKA), which phosphorylates numerous downstream targets involved in steroidogenesis .

Steroidogenesis: PKA activation leads to increased expression of steroidogenic acute regulatory (StAR) protein, which facilitates cholesterol transport into the mitochondria the rate-limiting step in steroid hormone synthesis . This cascade results in increased testosterone production in Leydig cells and progesterone production in ovarian cells. p s y c h e d e l i c g u i d e e x p l a i ned.

Extended Duration: Due to its glycosylation and sialic acid content, HCG has a plasma half-life of approximately 24-36 hours, significantly longer than LH (20-30 minutes), enabling sustained receptor activation .

Key Research Applications

Male Reproductive Endocrinology Research

HCG is extensively used in studies investigating testicular function, Leydig cell biology, and male fertility:

Leydig Cell Stimulation: Investigate the regulation of testosterone biosynthesis and steroidogenesis
Testicular Development: Study the effects of LH receptor activation on testicular growth and maturation
Spermatogenesis Research: Explore the role of intratesticular testosterone in sperm production
Hypogonadism Models: Investigate therapeutic strategies for primary and secondary hypogonadism

Female Reproductive Endocrinology Research

In female reproductive research, HCG serves as a valuable tool for studying ovarian function:

Ovulation Induction: Study the mechanisms of follicle rupture and oocyte maturation
Corpus Luteum Support: Investigate the role of LH receptor activation in progesterone production
Ovarian Steroidogenesis: Explore the regulation of estradiol and progesterone synthesis
Polycystic Ovary Syndrome (PCOS): Research the pathophysiology of ovarian dysfunction

Fertility and Assisted Reproduction Research

HCG is a critical tool in fertility research and assisted reproductive technologies:

Oocyte Maturation: Study the final stages of oocyte development and meiotic maturation
Embryo Implantation: Investigate the role of HCG in endometrial receptivity and implantation
Luteal Phase Support: Research the maintenance of early pregnancy and progesterone production

Androgen Research

HCG’s ability to stimulate testosterone production makes it valuable for studying androgen physiology:

Testosterone Biosynthesis: Investigate the steroidogenic pathway and rate-limiting steps
Androgen Receptor Research: Study the effects of endogenous testosterone on target tissues
Hypogonadism Models: Explore the mechanisms and treatment of low testosterone states

Cryptorchidism Research

HCG has been studied in models of undescended testes:

Testicular Descent: Investigate the hormonal regulation of gubernacular development
Leydig Cell Function: Study the effects of early HCG exposure on testicular development

Delayed Puberty Research

HCG is used in research models investigating the endocrine regulation of puberty:

Pubertal Onset: Study the role of LH receptor activation in initiating pubertal development
Gonadarche: Investigate the mechanisms of testicular and ovarian maturation

Quality Assurance: Setting the Standard for Research Compounds

Manufacturing Excellence

Eupharmaceutical sources HCG Peptide from certified GMP facilities with rigorous quality control protocols:

HPLC Purity Analysis: ≥98% purity verified by high-performance liquid chromatography
Mass Spectrometry Verification: Molecular weight confirmation via LC-HRMS
Bioactivity Testing: Verified in cell-based assays for LHCGR activation and cAMP production
Batch-Specific Certificates of Analysis: Complete documentation for each production run
Research-Use Only (RUO) Labeling: Full compliance with research compound regulations

Chemical and Product Specifications

Specification	Detail
Product Name	HCG Peptide (Human Chorionic Gonadotropin)
CAS Number	9002-61-3
Molecular Weight	~36,700 Da (heterodimer)
Alpha Subunit	92 amino acids (14,500 Da)
Beta Subunit	145 amino acids (22,500 Da)
Purity	≥98% (HPLC verified)
Potency	5000 IU per vial
Appearance	White to off-white lyophilized powder
Form	Lyophilized powder
Solubility	Soluble in sterile water, bacteriostatic water, or PBS
Target Receptor	Luteinizing hormone/choriogonadotropin receptor (LHCGR)
Half-Life	Approximately 24-36 hours
Storage (Lyophilized)	2-8°C; protect from light and moisture
Storage (Reconstituted)	2-8°C for short-term; do not freeze
Shelf Life	24 months from date of manufacture (lyophilized)
Intended Use	Research and laboratory use only
Documentation	Certificate of Analysis provided with each batch

Stability and Handling Guidelines

Lyophilized Powder Storage: Store lyophilized HCG powder at 2-8°C in a dry, dark environment, protected from light and moisture . Under proper storage conditions, the powder maintains stability for up to 24 months from the date of manufacture. Do not freeze the lyophilized powder .

Reconstitution Protocol:

Allow vial and solvent to reach ambient temperature before opening to prevent condensation
Reconstitute using sterile water or bacteriostatic water according to research protocol
Inject solvent slowly down the inside wall of the vial to minimize foaming
Gently swirl or roll the vial until fully dissolved—do not shake vigorously
Label the vial with the date of reconstitution and concentration (IU/mL)
Refrigerate immediately at 2-8°C

Reconstituted Solution Storage: Reconstituted HCG should be stored at 2-8°C and used within 30-60 days . Do not freeze reconstituted HCG, as freezing may denature the glycoprotein and reduce biological activity. Discard any unused solution after the recommended storage period.

Protection from Light and Moisture:

Store in original packaging protected from light
Keep vials tightly sealed when not in use
Allow refrigerated vials to reach room temperature before opening to prevent condensation.

Key Benefits

Premium Quality Manufacturing: GMP-certified production, ≥98% HPLC-verified purity with lot-specific COAs
Well-Characterized Glycoprotein: Over 90 years of research establishing its biological activity
Potent LHCGR Agonist: High-affinity binding to luteinizing hormone/choriogonadotropin receptors
Extended Half-Life: 24-36 hour duration for sustained receptor activation studies
Testosterone Stimulation: Potent inducer of Leydig cell steroidogenesis in male research models
Ovulation Induction: Critical tool for studying oocyte maturation and follicular rupture
Corpus Luteum Support: Essential for investigating luteal phase function and progesterone production
Fertility Research: Widely used in assisted reproduction and fertility studies
Hypogonadism Models: Valuable for studying primary and secondary hypogonadism
Cryptorchidism Research: Investigated in models of testicular descent and development
Delayed Puberty Studies: Used to study gonadarche and pubertal onset mechanisms
Stable Formulation: 24-month shelf life under proper storage conditions
Comprehensive Documentation: Certificates of Analysis with batch-specific purity data
48-Hour EU & UK Delivery: Rapid shipping to research facilities across Europe
Batch Consistency: Rigorous quality control ensures lot-to-lot reproducibility
EU Sourced: Available from within the European Union

Frequently Asked Questions

Q: What is HCG and how does it work?

A: HCG (Human Chorionic Gonadotropin) is a glycoprotein hormone that acts as a potent agonist of the luteinizing hormone/choriogonadotropin receptor (LHCGR) . It stimulates steroidogenesis in Leydig cells (testosterone production) and theca/granulosa cells (progesterone/estradiol production) through cAMP/PKA signaling .

Q: What is the difference between HCG and LH?

A: HCG and LH share the same receptor (LHCGR) but differ in half-life and structure. HCG has a longer half-life (24-36 hours) due to its glycosylation and sialic acid content, while LH has a short half-life (20-30 minutes) . HCG also contains a unique carboxy-terminal peptide that extends its duration of action .

Q: What purity level can I expect when I buy HCG from Eupharmaceutical?

A: All HCG Peptide from Eupharmaceutical is tested to ≥98% purity by HPLC, with Certificates of Analysis provided with every order . Each batch is individually analyzed, ensuring you receive material suitable for rigorous research applications.

Q: What is the molecular weight and structure of HCG?

A: HCG is a heterodimeric glycoprotein with a molecular weight of approximately 36,700 Da . It consists of an alpha subunit (92 amino acids, 14,500 Da) identical to LH, FSH, and TSH, and a unique beta subunit (145 amino acids, 22,500 Da) that confers biological specificity. m a g i c m u s h r o o m s.

Q: How should I store HCG for long-term stability?

A: Store lyophilized HCG powder at 2-8°C, protected from light and moisture . Under proper storage conditions, the powder maintains stability for up to 24 months. After reconstitution, store at 2-8°C and use within 30-60 days. Do not freeze reconstituted HCG .

Q: What is the solubility of HCG?

A: HCG is soluble in sterile water, bacteriostatic water, or PBS . Reconstitute according to research protocol to achieve desired concentration (typically 500-5000 IU/mL) .

Q: What research areas commonly use HCG?

A: HCG is widely used in male reproductive endocrinology research (Leydig cell stimulation, testicular function, spermatogenesis), female reproductive endocrinology research (ovulation induction, corpus luteum support), fertility and assisted reproduction research, androgen research, hypogonadism models, cryptorchidism research, and delayed puberty studies .

Q: What is the mechanism of action of HCG?

A: HCG binds to the luteinizing hormone/choriogonadotropin receptor (LHCGR), a G protein-coupled receptor . This activates adenylyl cyclase, increases cAMP, activates PKA, and stimulates steroidogenic acute regulatory (StAR) protein expression, leading to increased steroid hormone production .

Q: Do you ship HCG to EU countries?

A: Yes. As a dedicated EU peptide supplier, we ship HCG Peptide to all European Union member states with our guaranteed 48 hour delivery peptide service. Our EU fulfilment centre ensures rapid delivery without customs delays. All shipments use protective packaging to maintain compound integrity during transit.

Q: What documentation do you provide with HCG orders?

A: Every order includes a Certificate of Analysis (COA) with batch-specific purity data . Additional documentation, including HPLC chromatograms and mass spectrometry data, is available upon request for researchers requiring comprehensive analytical verification.

Q: Does HCG cross-react with other hormone receptors?

A: HCG is highly specific for the luteinizing hormone/choriogonadotropin receptor (LHCGR) . Due to its alpha subunit homology, it may have minimal activity at other glycoprotein hormone receptors, but its primary and most potent effects are mediated through LHCGR.

Q: Do you offer bulk quantities of HCG for institutional research?

A: Yes. We accommodate bulk orders for research institutions. Contact our team at contact@eupharmaceutical.com for volume pricing, custom requirements, and supply agreements for ongoing research programs. Be s t p syc h e d e l i c t h e r a p y e x p l a i n e d

Advance Your Research with HCG Peptide

Eupharmaceutical is your trusted source for HCG Peptide, the premium choice for researchers investigating reproductive endocrinology, testicular function, and LH receptor signaling. With nearly a century of research establishing its role as a potent agonist of the luteinizing hormone/choriogonadotropin receptor, HCG represents a fundamental tool for understanding the molecular mechanisms of steroidogenesis and fertility .

Whether you are exploring Leydig cell biology, designing ovulation studies, investigating hypogonadism mechanisms, or researching fertility pathways, our rigorously tested compound provides the quality and consistency your work demands.

Order today and experience the Eupharmaceutical difference premium quality, rapid 48-hour delivery across the EU and UK, and expert support for the European research community.